FIRST AIRED: May 27, 2016

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

We've got more news

Get our editor’s daily email summary of what’s going on in the world.

US Edition
Intl. Edition
Replay Program
More Info

COMING UP:Share Opener Variant 3



>> Politicians and health officials around the globe on Friday, sounding alarms about antibiotic resistant superbugs. British Prime Minister David Cameron, urging G7 powers to reduce the use of antibiotics in order to maintain their effectiveness. And to reward drug companies for developing new medicines.>> In too many cases, antibiotics have stopped working.
Cameron's remarks coming one day after researchers identified the first US patient with bacteria resistant to colistin, known as a last resort antibiotic. The patient, a 49 year old Pennsylvania woman, was treated for a urinary tract infection. A clinic sent results from her urine test to the Walter Reed Army Hospital, which identified the bacteria.
Reuters Healthcare Correspondent, Lance Del Pearson.>> Now the real demand is for other hospitals and for any healthcare providers of all stripes to really get together. And try to find surveillance methods to track down this thing. So they can know how quickly it's spreading, where its spreading in the United States.
There really is a sense of urgency today in the medical community.>> A UK medical group review warning that antibiotic resistance could kill an extra 10 million people a year by 2020 if not controlled. GlaxoSmithKline and Sempra are among the pharmaceutical companies still developing new treatments. Drug makers have been reluctant to invest in new antibiotics, preferring to focus on more profitable disease areas.
But with additional cases in China, Europe and Canada over the past year, the growing superbug threat has prompted a recent boost in funding.